V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200001540 | 200015298 | 1.76 | 61 | Palliative (P) | null | 2020-02-07 | null | null | N | TRIAL UNSPECIFIED | 100038584 |
| 200001568 | 200015299 | 1.82 | 92.6 | Palliative (P) | 2019-04-14 | 2019-05-21 | Fulvestrant + Palbociclib | 02 | null | BINIMETINIB + ENCORAFENIB | 101761142 |
| 200001597 | 200015300 | 1.68 | 82.9 | null | 2017-08-07 | 2017-08-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | BINIMETINIB + ENCORAFENIB | 100742225 |
| 200001766 | 200015303 | 1.49 | null | null | null | 2018-12-26 | null | null | null | TALIMOGENE LAHERPAREPVEC | 101279198 |
| 200001809 | 200015304 | 1.76 | 118 | Palliative (P) | null | 2021-01-31 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101608452 |
| 200001820 | 200015305 | 1.69 | null | null | null | 2016-06-04 | null | null | null | CAPECITABINE + IRINOTECAN | 100908953 |
| 200001857 | 200015308 | 1.85 | 69.2 | Palliative (P) | null | 2020-05-15 | null | null | null | ISATUXIMAB + POMALIDOMIDE | 101721312 |
| 200001935 | 200015312 | 1.66 | 69.2 | Palliative (P) | null | 2018-06-18 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100341567 |
| 200002028 | 200015313 | null | null | null | null | 2019-04-02 | null | null | null | TRIAL UNSPECIFIED | 101072135 |
| 200002188 | 200015314 | 1.9 | 74.8 | Palliative (P) | null | 2018-03-18 | null | null | N | TALIMOGENE LAHERPAREPVEC | 100467259 |
| 200002361 | 200015316 | 1.84 | 87.4 | 03 | null | 2018-07-02 | null | null | N | INTERIM TRIAL | 100126973 |
| 200002657 | 200015321 | 1.72 | 64 | Palliative (P) | null | 2019-03-15 | null | null | null | IPILIMUMAB | 100316541 |
| 200002754 | 200015326 | 1.47 | 102.6 | Adjuvant (A) | 2021-03-30 | 2021-04-04 | INTERIM Trial | N | null | IPILIMUMAB + NIVOLUMAB | 101691798 |
| 200002817 | 200015330 | 1.77 | 104 | Palliative (P) | 2019-05-27 | 2019-06-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101065953 |
| 200002858 | 200015331 | 1.68 | null | null | null | 2019-03-18 | null | null | null | DABRAFENIB | 101853595 |
| 200003018 | 200015336 | 1.66 | null | null | null | 2019-10-22 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100707524 |
| 200003077 | 200015337 | 1.9 | 70.5 | null | 2021-06-03 | 2021-06-08 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101484698 |
| 200003122 | 200015338 | 1.79 | null | null | null | 2015-02-18 | null | null | null | TRIAL | 101536980 |
| 200003144 | 200015342 | 1.6 | 106 | Palliative (P) | 2017-09-10 | 2018-12-13 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101367541 |
| 200003233 | 200015343 | 1.68 | 82 | Neo-adjuvant (N) | null | 2019-12-24 | null | null | null | TRIAL UNSPECIFIED | 101270006 |
| 200003238 | 200015344 | 1.68 | 83.3 | Palliative (P) | 2021-07-10 | 2021-07-10 | Liposomal Doxorubicin 50mg/m2 | 01 | null | TRIAL UNSPECIFIED | 101498370 |
| 200003247 | 200015346 | null | null | null | null | 2018-10-03 | null | null | null | INTERIM TRIAL | 100188585 |
| 200003333 | 200015349 | 1.74 | 76.7 | Palliative (P) | null | 2018-05-02 | null | null | N | INTERIM TRIAL | 101500642 |
| 200003381 | 200015350 | 1.75 | 88.5 | Adjuvant (A) | null | 2019-03-06 | null | null | N | DABRAFENIB | 101805733 |
| 200003382 | 200015351 | 1.76 | null | null | null | 2022-05-16 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100296390 |
| 200003410 | 200015352 | 1.76 | null | null | null | 2018-12-25 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100393782 |
| 200003432 | 200015353 | 1.53 | 55.4 | Adjuvant (A) | null | 2020-08-03 | null | null | N | BINIMETINIB | 101474082 |
| 200003532 | 200015356 | 1.61 | null | null | null | 2018-01-25 | null | null | null | IPILIMUMAB | 100844652 |
| 200003551 | 200015357 | 1.58 | 45.6 | Palliative (P) | null | 2020-11-10 | null | null | N | TALIMOGENE LAHERPAREPVEC | 100586349 |
| 200003560 | 200015359 | null | null | null | null | 2019-01-08 | null | null | null | TRIAL | 100542532 |
| 200003701 | 200015364 | null | null | null | null | 2019-07-08 | null | null | null | TRIAL UNSPECIFIED | 100027317 |
| 200003769 | 200015365 | null | null | null | null | 2018-11-15 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100958037 |
| 200003788 | 200015366 | null | null | null | null | 2021-01-04 | null | null | null | CAPECITABINE | 100857613 |
| 200004080 | 200015372 | null | null | null | null | 2018-06-12 | null | null | null | COLUMBUS TRIAL | 100658805 |
| 200004148 | 200015376 | null | null | null | null | 2019-09-28 | null | null | null | LENALIDOMIDE | 100943268 |
| 200004203 | 200015377 | 1.83 | 64.4 | Adjuvant (A) | 2021-10-02 | 2021-10-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101530997 |
| 200004273 | 200015380 | null | 72.3 | Palliative (P) | null | 2021-01-30 | null | null | null | BINIMETINIB + ENCORAFENIB | 100222672 |
| 200004277 | 200015381 | 1.69 | null | null | null | 2017-05-26 | null | null | null | TRIAL UNSPECIFIED | 101665369 |
| 200004305 | 200015384 | 1.72 | null | null | null | 2019-04-22 | null | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 101768850 |
| 200004331 | 200015389 | 1.61 | 71.1 | Curative (C) | null | 2022-05-21 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101266400 |
| 200004396 | 200015391 | null | null | null | null | 2019-06-15 | null | null | null | DABRAFENIB | 101038790 |
| 200004500 | 200015394 | 1.7 | null | null | null | 2016-03-21 | null | null | null | BINIMETINIB + ENCORAFENIB | 100843414 |
| 200004626 | 200015397 | null | null | null | null | 2017-10-30 | null | null | null | TRIAL UNSPECIFIED | 101472557 |
| 200004699 | 200015398 | 1.8 | 97.9 | Palliative (P) | null | 2019-02-27 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101785816 |
| 200004712 | 200015399 | 1.74 | 81.8 | 03 | null | 2017-07-17 | null | null | N | TRIAL UNSPECIFIED | 101856181 |
| 200004713 | 200015400 | null | null | null | null | 2018-06-06 | null | null | null | INTERIM TRIAL | 101535624 |
| 200004718 | 200015402 | null | 61 | Palliative (P) | null | 2020-12-22 | null | null | N | INTERIM TRIAL | 101605375 |
| 200004726 | 200015403 | null | null | null | null | 2017-05-17 | null | null | null | TRASTUZUMAB | 100550489 |
| 200004779 | 200015404 | 1.74 | 0 | Adjuvant (A) | null | 2021-05-06 | null | null | null | BLEOMYCIN + CISPLATIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 100915972 |
| 200004819 | 200015405 | 1.4 | 76.7 | Adjuvant (A) | null | 2018-11-05 | null | null | null | ENCORAFENIB | 100960418 |